GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Unionkorea Pharm Co Ltd (XKRX:080720) » Definitions » Net Income Including Noncontrolling Interests

Unionkorea Pharm Co (XKRX:080720) Net Income Including Noncontrolling Interests : ₩-20,433 Mil (TTM As of Mar. 2025)


View and export this data going back to 2018. Start your Free Trial

What is Unionkorea Pharm Co Net Income Including Noncontrolling Interests?

Net Income Including Noncontrolling Interests is the net income of the group after the adjustment of all expenses and benefit. It includes the net income (loss) attributable to noncontrolling and redeemable noncontrolling interests and the net income (loss) attributable to the company.

Unionkorea Pharm Co's Net Income Including Noncontrolling Interests for the three months ended in Mar. 2025 was ₩-2,561 Mil. Its Net Income Including Noncontrolling Interests for the trailing twelve months (TTM) ended in Mar. 2025 was ₩-20,433 Mil.


Unionkorea Pharm Co Net Income Including Noncontrolling Interests Historical Data

The historical data trend for Unionkorea Pharm Co's Net Income Including Noncontrolling Interests can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Unionkorea Pharm Co Net Income Including Noncontrolling Interests Chart

Unionkorea Pharm Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Net Income Including Noncontrolling Interests
Get a 7-Day Free Trial Premium Member Only Premium Member Only -9,322.44 -11,109.45 -932.02 -18,156.30 -20,872.13

Unionkorea Pharm Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Net Income Including Noncontrolling Interests Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -3,000.34 -3,825.50 -1,314.78 -12,731.51 -2,560.85

Unionkorea Pharm Co Net Income Including Noncontrolling Interests Calculation

Net Income Including Noncontrolling Interests is the net income of the group after the adjustment of all expenses and benefit. It includes the net income (loss) attributable to noncontrolling and redeemable noncontrolling interests and the net income (loss) attributable to the company.

Net Income Including Noncontrolling Interests for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩-20,433 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Unionkorea Pharm Co Net Income Including Noncontrolling Interests Related Terms

Thank you for viewing the detailed overview of Unionkorea Pharm Co's Net Income Including Noncontrolling Interests provided by GuruFocus.com. Please click on the following links to see related term pages.


Unionkorea Pharm Co Business Description

Industry
Traded in Other Exchanges
N/A
Address
4th Floor, 417, Samwhan-HIPEX A Tower B/D 240, Pangyoyeok-ro, Bundang-gu, Seongnam-si, Gyeonggi-do, KOR, 13493
Unionkorea Pharm Co Ltd is a pharmaceutical company. The company is engaged in the development, manufacturing and marketing of brain metabolism enhancer, prescription drugs, Anti-inflammatory analgesics, and skeletal muscle relaxants.

Unionkorea Pharm Co Headlines

No Headlines